These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3361397)

  • 1. Treatment with dexamethasone of androgen excess in adolescent patients.
    Emans SJ; Grace E; Woods ER; Mansfield J; Crigler JF
    J Pediatr; 1988 May; 112(5):821-6. PubMed ID: 3361397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of combined cyproterone acetate-ethinyl oestradiol therapy on serum levels of dehydroepiandrosterone, androstenedione, and testosterone in hirsute women.
    Frölich M; Lachinsky N; Moolenaar AJ
    Acta Endocrinol (Copenh); 1977 Feb; 84(2):333-42. PubMed ID: 138326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of spironolactone in treatment of hirsutism.
    Cumming DC
    Cleve Clin J Med; 1990 May; 57(3):285-7. PubMed ID: 2357784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of DHEAS in gynecologic endocrinopathy and infertility.
    Lobo RA; Paul WL; Goebelsmann U
    Obstet Gynecol; 1981 May; 57(5):607-12. PubMed ID: 6261197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral contraceptive pills, gonadotropin-releasing hormone agonists, or use in combination for treatment of hirsutism: a clinical research center study.
    Carr BR; Breslau NA; Givens C; Byrd W; Barnett-Hamm C; Marshburn PB
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1169-78. PubMed ID: 7714086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral androgen blockade versus glandular androgen suppression in the treatment of hirsutism.
    Carmina E; Lobo RA
    Obstet Gynecol; 1991 Nov; 78(5 Pt 1):845-9. PubMed ID: 1833685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between urinary 17-ketosteroids and serum androgens in hirsute patients.
    Maroulis GB; Manlimos FS; Abraham GE
    Obstet Gynecol; 1977 Apr; 49(4):454-8. PubMed ID: 140340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic evaluation of hirsutism in women.
    Farber M; Millan VG; Turksoy RN; Mitchell GW
    Clin Obstet Gynecol; 1977 Mar; 20(1):1-9. PubMed ID: 837574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Daily serum follicle-stimulating hormone, luteinizing hormone, and plasma testosterone and androstenedione in hirsute women with polycystic sclerotic ovaries: effects of diethylstilbestrol and norethindrone acetats.
    Daane TA; Dignam WJ; Frankland MV; Simmer HH; Parlow AF
    Am J Obstet Gynecol; 1973 Oct; 117(3):392-9. PubMed ID: 4729733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuation of mild hyperandrogenic activity in postpubertal acne by a triphasic oral contraceptive containing low doses of ethynyl estradiol and d,l-norgestrel.
    Lemay A; Dewailly SD; Grenier R; Huard J
    J Clin Endocrinol Metab; 1990 Jul; 71(1):8-14. PubMed ID: 2142494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of the effects of dexamethasone administration on urinary 17-ketosteroid and serum androgen levels in patients with hirsutism.
    Judd HL; McPherson RA; Rakoff JS; Yen SS
    Am J Obstet Gynecol; 1977 Jun; 128(4):408-17. PubMed ID: 141210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hirsutism: diagnostic approach and stimulation-suppression dynamics of androgens in the female.
    Biberoglu K; Behrman SJ
    Int J Fertil; 1982; 27(3):146-52. PubMed ID: 6128319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of dexamethasone and clomiphene citrate on peripheral steroid levels and ovarian function in a hirsute amenorrheic patient.
    Chang RJ; Abraham GE
    Fertil Steril; 1976 Jun; 27(6):640-6. PubMed ID: 132375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity of cortisol and adrenal androgens to dexamethasone suppression in hirsute women.
    Rittmaster RS; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1985 Sep; 61(3):462-6. PubMed ID: 2991319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovulation after glucocorticoid suppression of adrenal androgens in the polycystic ovary syndrome is not predicted by the basal dehydroepiandrosterone sulfate level.
    Azziz R; Black VY; Knochenhauer ES; Hines GA; Boots LR
    J Clin Endocrinol Metab; 1999 Mar; 84(3):946-50. PubMed ID: 10084576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of androgens in menstrual disorders of nonhirsute and hirsute women, and the effect of glucocorticoid therapy on androgen levels in hirsute hyperandrogenic women.
    Ho Yuen B; Mincey EK
    Am J Obstet Gynecol; 1983 Jan; 145(2):152-7. PubMed ID: 6401396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hirsutism: implications, etiology, and management.
    Hatch R; Rosenfield RL; Kim MH; Tredway D
    Am J Obstet Gynecol; 1981 Aug; 140(7):815-30. PubMed ID: 7258262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leuprolide and estrogen versus oral contraceptive pills for the treatment of hirsutism: a prospective randomized study.
    Azziz R; Ochoa TM; Bradley EL; Potter HD; Boots LR
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3406-11. PubMed ID: 8530573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High serum prostate-specific antigen concentrations in hirsute women do not decrease with treatment by the combination of spironolactone and the contraceptive pill.
    Guzelmeric K; Seker N; Unal O; Turan C
    Gynecol Endocrinol; 2004 Oct; 19(4):190-5. PubMed ID: 15724801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.
    Handelsman DJ; Conway AJ; Howe CJ; Turner L; Mackey MA
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4113-21. PubMed ID: 8923869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.